| |
|
|
|
Trillium Therapeutics Inc.  
|
|
0.66 -0.03 (-0.04%) |
03-22 15:59 |
|
Open: |
0.7 |
Pre close: |
0.69 |
Target:
|
1.21
|
|
High: |
0.72 |
Low: |
0.66 |
Resistance:
|
1.04
1.34
|
|
Volume: |
1,157,073 |
Market Cap: |
14M |
Support:
|
0.55
0.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.67
 |
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
0.69  |
Signal(12,26,9): |
-0.18 |
|
MA(100): |
1.82 |
Stochastic Oscillator |
%K(14,3):
|
40.20 |
|
MA(250): |
4.21 |
%D(3): |
38.63 |
|
Average Volume(K) |
3-Month: |
55814
|
52-Week |
High:
|
8.10 |
|
10-Days: |
135709 |
Low: |
0.55 |
|
RSI |
RSI(14):
|
35.10 |
Change(%): |
-91.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.340 |
Return on Equity (ttm) |
-427.8 |
Shares Out. (M) |
21.24 |
|
EPS Est. Current Year |
-4.130 |
Return on Assets (ttm) |
-56.7 |
Shares Float (M) |
21.24 |
|
EPS Est. Next Year |
-2.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.960 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
47.30 |
|
Forward EPS |
-2.917 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
7.670 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.09 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
